METHODS: We performed a thorough search of 6 databases until March 2023, identifying 12 randomized controlled trials that met our predefined inclusion criteria and encompassed a total of 1510 patients. For continuous outcomes, we calculated the weighted mean difference (WMD), and for binomial outcomes, we used the risk ratio (RR). We evaluated heterogeneity among the included studies using Cochran I2 and Q statistics, utilizing a random-effects model when the I2 value exceeded 50%. To assess publication bias, we employed Egger test.
RESULTS: Our analysis found that TEAS significantly reduced the risk of postoperative nausea (RR: 0.60, 95% CI: 0.43-0.83, P = .002) and postoperative vomiting (RR: 0.54, 95% CI: 0.43-0.67, P < .001), visual analogue scale (WMD: -0.47, 95% CI: -0.76 to -0.17, P = .002), as well as shortened the time to first bowel movement (WMD: -18.43, 95% CI: -20.87 to -15.99, P < .001) and time to first flatus (WMD: -8.98, 95% CI: -12.46 to -5.51, P < .001) compared to the conventional group.
CONCLUSIONS: Our findings suggested that TEAS may improve postoperative recovery following gynecologic surgery. However, to confirm these results, larger randomized controlled trials encompassing a more diverse range of patient populations are urgently required.
方法:我们对6个数据库进行了彻底搜索,直到2023年3月,确定了12项符合我们预定纳入标准的随机对照试验,共涵盖1510名患者。对于连续的结果,我们计算了加权平均差(WMD),对于二项式结果,我们使用了风险比(RR)。我们使用CochranI2和Q统计量评估了纳入研究的异质性,当I2值超过50%时,利用随机效应模型。为了评估出版偏见,我们采用了Egger测试。
结果:我们的分析发现,TEAS显着降低了术后恶心(RR:0.60,95%CI:0.43-0.83,P=.002)和术后呕吐(RR:0.54,95%CI:0.43-0.67,P<.001)的风险,视觉模拟量表(WMD:-0.47,95%CI:-0.76至-0.17,P=0.002),与常规组相比,首次排便时间缩短(WMD:-18.43,95%CI:-20.87至-15.99,P<.001)和首次排气时间缩短(WMD:-8.98,95%CI:-12.46至-5.51,P<.001)。
结论:我们的研究结果表明,TEAS可以改善妇科手术后的恢复。然而,为了证实这些结果,我们迫切需要更大的随机对照试验,包括更多不同的患者人群.